Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers
Taylor LLP are investigating potential claims against the Board of
Directors of Cadence Pharmaceuticals Inc. (“Cadence”) (NasdaqGS: CADX)
related to the sale to Mallinckrodt plc for shareholders. Cadence
shareholders will receive just $14.00 in cash for each share owned under
the terms of the transaction, which is well below an analyst estimated
$15.00 per share.
If you are an affected investor, and you want to learn more about the
lawsuit or join the action, contact Willie Briscoe at The Briscoe Law
Firm, PLLC, (214) 239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com,
or Patrick Powers at Powers Taylor LLP, toll free (877) 728-9607, via
e-mail at shareholder@powerstaylor.com.
There is no cost or fee to you.
The Cadence investigation centers on whether Cadence’s Board of
Directors is acting in the shareholders’ best interests, whether the
board is properly considering the proposed price for the shareholders,
and whether the board has employed an adequate process to review and act
on the proposed transaction. Notably, at least one analyst with Yahoo!
Finance estimates the Company could be worth as high as $15 per share.
The
Briscoe Law Firm, PLLC is a full service business litigation and
shareholder rights advocacy firm with more than 20 years of experience
in complex litigation and transactional matters.
Powers
Taylor LLP is a boutique litigation law firm that handles a variety
of complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits,
and security class actions.
Copyright Business Wire 2014